Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer.
about
Prognostic value of circulating endothelial cells in metastatic colorectal cancer.Biomarkers for anti-angiogenic therapy in cancer.Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.Targeted therapies in colorectal cancer-an integrative view by PPPMFlow cytometric analysis of circulating endothelial cells and endothelial progenitors for clinical purposes in oncology: A critical evaluation.Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients.Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.Bevacizumab: a review of its use in advanced cancer.Predictive biomarker candidates to delineate efficacy of antiangiogenic treatment in renal cell carcinoma.Circulating endothelial cells and their subsets: novel biomarkers for cancer.Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients.Isolation of a circulating CD45-, CD34dim cell population and validation of their endothelial phenotype.Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment.The role of automated cytometry in the new era of cancer immunotherapy
P2860
Q33913995-743AFDFE-0989-4D19-851B-59CB1DE1FD9DQ34695003-7448F157-BC68-4E5A-A3BE-D2E02EB5DC7CQ34902070-0ED4EDC9-27D0-442C-AC2E-F0E9DDE38E33Q36646911-652AC5DD-B646-4DC6-AEE2-52AF481ECA05Q36954000-0E869ABE-8549-471E-8A68-CE7659D08223Q37408810-320F14B5-7AF2-4640-89C8-F9C0B7C18B36Q38166233-7AF78750-9931-4E38-BE02-14A7134AA862Q38260176-C9AB1AE5-15A5-428A-97E7-023D81D73C06Q38546217-63610771-4832-4B1C-99DC-D2C95D153944Q38672972-D1F3D73B-366C-4FE4-84B7-18FFAF48431EQ48124045-531050F5-DA77-444A-9264-FBBC7FAC1686Q54456361-78DFE36F-D51F-41EE-9B96-2B29E974E416Q55192756-F766E20F-732D-49A9-BBB1-089BD7416D03Q58733431-9D00F4F0-B75F-4D8A-A74A-991E346BFE6D
P2860
Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Circulating endothelial cells ...... or advanced colorectal cancer.
@en
Circulating endothelial cells ...... or advanced colorectal cancer.
@nl
type
label
Circulating endothelial cells ...... or advanced colorectal cancer.
@en
Circulating endothelial cells ...... or advanced colorectal cancer.
@nl
prefLabel
Circulating endothelial cells ...... or advanced colorectal cancer.
@en
Circulating endothelial cells ...... or advanced colorectal cancer.
@nl
P2093
P2860
P50
P921
P1476
Circulating endothelial cells ...... for advanced colorectal cancer
@en
P2093
Eugenio Villa
Marco Danova
Mariangela Manzoni
Silvia Brugnatelli
P2860
P2888
P304
P356
10.1007/S00432-012-1190-6
P50
P577
2012-03-15T00:00:00Z